Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
24 Jan 2023 |
GAZ2(A) |
Final Gazette dissolved via voluntary strike-off
|
|
|
13 Dec 2022 |
TM01 |
Termination of appointment of Mark Gibbons as a director on 8 November 2022
|
|
|
08 Nov 2022 |
GAZ1(A) |
First Gazette notice for voluntary strike-off
|
|
|
28 Oct 2022 |
DS01 |
Application to strike the company off the register
|
|
|
06 Oct 2022 |
CS01 |
Confirmation statement made on 4 October 2022 with no updates
|
|
|
23 Aug 2022 |
AP01 |
Appointment of Ms Seyda Atadan Memis as a director on 1 August 2022
|
|
|
27 Oct 2021 |
AA |
Full accounts made up to 31 December 2020
|
|
|
15 Oct 2021 |
CS01 |
Confirmation statement made on 3 October 2021 with no updates
|
|
|
01 Dec 2020 |
AA |
Full accounts made up to 31 December 2019
|
|
|
30 Nov 2020 |
TM01 |
Termination of appointment of Nicholas Hugh Meryon Insall as a director on 30 November 2020
|
|
|
07 Oct 2020 |
CS01 |
Confirmation statement made on 3 October 2020 with updates
|
|
|
15 Jun 2020 |
PSC02 |
Notification of Shire Pharmaceuticals Group as a person with significant control on 15 June 2020
|
|
|
15 Jun 2020 |
PSC07 |
Cessation of Takeda Pharmaceutical Company Limited as a person with significant control on 15 June 2020
|
|
|
28 Apr 2020 |
CH04 |
Secretary's details changed for Shire Corporate Services Limited on 28 April 2020
|
|
|
28 Feb 2020 |
RESOLUTIONS |
Resolutions
-
RES14 ‐
The sum of 7,906,459 be capitalised 25/02/2020
-
RES10 ‐
Resolution of allotment of securities
|
|
|
27 Feb 2020 |
SH01 |
Statement of capital following an allotment of shares on 25 February 2020
|
|
|
26 Feb 2020 |
SH20 |
Statement by Directors
|
|
|
26 Feb 2020 |
SH19 |
Statement of capital on 26 February 2020
|
|
|
26 Feb 2020 |
CAP-SS |
Solvency Statement dated 25/02/20
|
|
|
26 Feb 2020 |
RESOLUTIONS |
Resolutions
-
RES13 ‐
Cancellation of share premium account 25/02/2020
-
RES06 ‐
Resolution of reduction in issued share capital
|
|
|
07 Feb 2020 |
CH01 |
Director's details changed for Mr Jonathan Clark Neal on 6 February 2020
|
|
|
05 Dec 2019 |
AUD |
Auditor's resignation
|
|
|
10 Oct 2019 |
AA |
Full accounts made up to 31 December 2018
|
|
|
07 Oct 2019 |
CS01 |
Confirmation statement made on 3 October 2019 with no updates
|
|
|
29 May 2019 |
TM01 |
Termination of appointment of Damien Rodolphe Edmond Bailly as a director on 6 May 2019
|
|